|
|
||||||||
Clinical criteria for the diagnosis of Alzheimer's disease include insidious onset and progressive impairment of memory and other cognitive functions. There are no motor, sensory, or coordination deficits early in the disease. The diagnosis cannot be determined by laboratory tests. These tests are important primarily in identifying other possible causes of dementia that must be excluded before the diagnosis of Alzheimer's disease may be made with confidence. Neuropsychological tests provide confirmatory evidence of the diagnosis of dementia and help to assess the course and response to therapy. The criteria proposed are intended to serve as a guide for the diagnosis of probable, possible, and definite Alzheimer's disease; these criteria will be revised as more definitive information becomes available.
Address correspondence and reprint requests to Dr. Stadlan, 7550 Wisconsin Avenue, Federal Building, Room 700, Bethesda, MD 20205.
*For Work Group Participants and Affiliations, see page 943.
Accepted for publication March 20, 1984.
This article has been cited by other articles:
![]() |
X. Millet, N. Raoux, N. Le Carret, J. Bouisson, J.-F. Dartigues, and H. Amieva Gender-related Differences in Visuospatial Memory Persist in Alzheimer's Disease Arch Clin Neuropsychol, December 1, 2009; 24(8): 783 - 789. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bermejo-Pareja, J. Benito-Leon, S. Vega, J. Olazaran, M. de Toledo, J. Diaz-Guzman, F. Sanchez-Sanchez, J.M. Morales-Gonzalez, R. Trincado, A. Portera-Sanchez, et al. Consistency of Clinical Diagnosis of Dementia in NEDICES: A Population-Based Longitudinal Study in Spain J Geriatr Psychiatry Neurol, December 1, 2009; 22(4): 246 - 255. [Abstract] [PDF] |
||||
![]() |
L. Y. Wang, J. B. Leverenz, E. B. Larson, D. A. Vavrek, W. A. Kukull, W. McCormick, J. D. Bowen, L. Teri, T. Montine, and D. W. Tsuang Cognitive Impairment in Older Adults Without Dementia: Clinical and Pathologic Outcomes in a Community-Based Sample J Geriatr Psychiatry Neurol, December 1, 2009; 22(4): 256 - 265. [Abstract] [PDF] |
||||
![]() |
T. Leyhe, R. Saur, Gerhard. W. Eschweiler, and M. Milian Clock Test Deficits Are Associated With Semantic Memory Impairment in Alzheimer Disease J Geriatr Psychiatry Neurol, December 1, 2009; 22(4): 235 - 245. [Abstract] [PDF] |
||||
![]() |
L. J. Clark, M. Gatz, L. Zheng, Y.-L. Chen, C. McCleary, and W. J. Mack Longitudinal Verbal Fluency in Normal Aging, Preclinical, and Prevalent Alzheimer's Disease American Journal of Alzheimer's Disease and Other Dementias, December 1, 2009; 24(6): 461 - 468. [Abstract] [PDF] |
||||
![]() |
D. Y. Lee, E. Fletcher, O. Martinez, M. Ortega, N. Zozulya, J. Kim, J. Tran, M. Buonocore, O. Carmichael, and C. DeCarli Regional pattern of white matter microstructural changes in normal aging, MCI, and AD Neurology, November 24, 2009; 73(21): 1722 - 1728. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Migliaccio, F. Agosta, K. Rascovsky, A. Karydas, S. Bonasera, G. D. Rabinovici, B. L. Miller, and M. L. Gorno-Tempini Clinical syndromes associated with posterior atrophy: Early age at onset AD spectrum Neurology, November 10, 2009; 73(19): 1571 - 1578. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Molano, B. Boeve, T. Ferman, G. Smith, J. Parisi, D. Dickson, D. Knopman, N. Graff-Radford, Y. Geda, J. Lucas, et al. Mild cognitive impairment associated with limbic and neocortical lewy body disease: a clinicopathological study Brain, November 4, 2009; (2009) awp280v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Oulhaj, G. K. Wilcock, A. D. Smith, and C. A. de Jager Predicting the time of conversion to MCI in the elderly: Role of verbal expression and learning Neurology, November 3, 2009; 73(18): 1436 - 1442. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Vepsalainen, S Helisalmi, A Mannermaa, T Pirttila, H Soininen, and M Hiltunen Combined risk effects of IDE and NEP gene variants on Alzheimer disease J. Neurol. Neurosurg. Psychiatry, November 1, 2009; 80(11): 1268 - 1270. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Belohlavek, P. Jiamsripong, A. M. Calleja, E. M. McMahon, C. L. Maarouf, T. A. Kokjohn, T. L. Chaffin, L. J. Vedders, Z. Garami, T. G. Beach, et al. Patients With Alzheimer Disease Have Altered Transmitral Flow: Echocardiographic Analysis of the Vortex Formation Time J. Ultrasound Med., November 1, 2009; 28(11): 1493 - 1500. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Appel, E. Potter, N. Bhatia, Q. Shen, W. Zhao, M.T. Greig, A. Raj, W.W. Barker, H. Potter, E. Schofield, et al. Association of White Matter Hyperintensity Measurements on Brain MR Imaging with Cognitive Status, Medial Temporal Atrophy, and Cardiovascular Risk Factors AJNR Am. J. Neuroradiol., November 1, 2009; 30(10): 1870 - 1876. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Boyle, A. S. Buchman, R. S. Wilson, S. E. Leurgans, and D. A. Bennett Association of Muscle Strength With the Risk of Alzheimer Disease and the Rate of Cognitive Decline in Community-Dwelling Older Persons Arch Neurol, November 1, 2009; 66(11): 1339 - 1344. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Hayden, P. P. Zandi, N. A. West, J. T. Tschanz, M. C. Norton, C. Corcoran, J. C. S. Breitner, K. A. Welsh-Bohmer, and for the Cache County Study Group Effects of Family History and Apolipoprotein E {varepsilon}4 Status on Cognitive Decline in the Absence of Alzheimer Dementia: The Cache County Study Arch Neurol, November 1, 2009; 66(11): 1378 - 1383. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Reitz, A. M. Brickman, T. R. Brown, J. Manly, C. DeCarli, S. A. Small, and R. Mayeux Linking Hippocampal Structure and Function to Memory Performance in an Aging Population Arch Neurol, November 1, 2009; 66(11): 1385 - 1392. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. He, S. Farias, O. Martinez, B. Reed, D. Mungas, and C. DeCarli Differences in Brain Volume, Hippocampal Volume, Cerebrovascular Risk Factors, and Apolipoprotein E4 Among Mild Cognitive Impairment Subtypes Arch Neurol, November 1, 2009; 66(11): 1393 - 1399. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-z. Zhu, W.-d. Zhong, W. Wang, C.-j. Zhan, C.-y. Wang, J.-p. Qi, J.-z. Wang, and T. Lei Quantitative MR Phase-corrected Imaging to Investigate Increased Brain Iron Deposition of Patients with Alzheimer Disease Radiology, November 1, 2009; 253(2): 497 - 504. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D.C. Goos, M.I. Kester, F. Barkhof, M. Klein, M. A. Blankenstein, P. Scheltens, and W. M. van der Flier Patients With Alzheimer Disease With Multiple Microbleeds: Relation With Cerebrospinal Fluid Biomarkers and Cognition Stroke, November 1, 2009; 40(11): 3455 - 3460. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Kester, A. E. van der Vlies, M. A. Blankenstein, Y.A.L. Pijnenburg, E. J. van Elk, P. Scheltens, and W. M. van der Flier CSF biomarkers predict rate of cognitive decline in Alzheimer disease Neurology, October 27, 2009; 73(17): 1353 - 1358. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sanz, S. Andrieu, A. Sinclair, H. Hanaire, B. Vellas, and For the REAL.FR Study Group Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease Neurology, October 27, 2009; 73(17): 1359 - 1366. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kim, J. Suh, D. Romano, M. H. Truong, K. Mullin, B. Hooli, D. Norton, G. Tesco, K. Elliott, S. L. Wagner, et al. Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity Hum. Mol. Genet., October 15, 2009; 18(20): 3987 - 3996. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Abdul, M. A. Sama, J. L. Furman, D. M. Mathis, T. L. Beckett, A. M. Weidner, E. S. Patel, I. Baig, M. P. Murphy, H. LeVine 3rd, et al. Cognitive Decline in Alzheimer's Disease Is Associated with Selective Changes in Calcineurin/NFAT Signaling J. Neurosci., October 14, 2009; 29(41): 12957 - 12969. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Jagust, S. M. Landau, L. M. Shaw, J. Q. Trojanowski, R. A. Koeppe, E. M. Reiman, N. L. Foster, R. C. Petersen, M. W. Weiner, J. C. Price, et al. Relationships between biomarkers in aging and dementia Neurology, October 13, 2009; 73(15): 1193 - 1199. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Scheinin, S. Aalto, J. Koikkalainen, J. Lotjonen, M. Karrasch, N. Kemppainen, M. Viitanen, K. Nagren, S. Helin, M. Scheinin, et al. Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls Neurology, October 13, 2009; 73(15): 1186 - 1192. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Moreira, C. May, and J. Bond Regulatory Objectivity in Action: Mild Cognitive Impairment and the Collective Production of Uncertainty Social Studies of Science, October 1, 2009; 39(5): 665 - 690. [Abstract] [PDF] |
||||
![]() |
J. Suarez, M. C. Tartaglia, P. Vitali, A. Erbetta, J. Neuhaus, V. Laluz, and B. L. Miller CHARACTERIZING RADIOLOGY REPORTS IN PATIENTS WITH FRONTOTEMPORAL DEMENTIA Neurology, September 29, 2009; 73(13): 1073 - 1074. [Full Text] [PDF] |
||||
![]() |
K. L. Triebel, R. Martin, H. R. Griffith, J. Marceaux, O. C. Okonkwo, L. Harrell, D. Clark, J. Brockington, A. Bartolucci, and D. C. Marson Declining financial capacity in mild cognitive impairment: A 1-year longitudinal study Neurology, September 22, 2009; 73(12): 928 - 934. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.J.P. Henneman, H. Vrenken, J. Barnes, I. C. Sluimer, N. A. Verwey, M. A. Blankenstein, M. Klein, N. C. Fox, P. Scheltens, F. Barkhof, et al. Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease Neurology, September 22, 2009; 73(12): 935 - 940. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. -C. Lambert, S. Schraen-Maschke, F. Richard, N. Fievet, O. Rouaud, C. Berr, J. -F. Dartigues, C. Tzourio, A. Alperovitch, L. Buee, et al. Association of plasma amyloid {beta} with risk of dementia: The prospective Three-City Study Neurology, September 15, 2009; 73(11): 847 - 853. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. N. Akbaraly, F. Portet, S. Fustinoni, J. -F. Dartigues, S. Artero, O. Rouaud, J. Touchon, K. Ritchie, and C. Berr Leisure activities and the risk of dementia in the elderly: Results from the Three-City Study Neurology, September 15, 2009; 73(11): 854 - 861. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pilotto, M. Franceschi, G. D'Onofrio, A. Bizzarro, F. Mangialasche, L. Cascavilla, F. Paris, M. G. Matera, A. Pilotto, A. Daniele, et al. Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease Neurology, September 8, 2009; 73(10): 761 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Holmes, C. Cunningham, E. Zotova, J. Woolford, C. Dean, S. Kerr, D. Culliford, and V. H. Perry Systemic inflammation and disease progression in Alzheimer disease Neurology, September 8, 2009; 73(10): 768 - 774. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Okello, J. Koivunen, P. Edison, H. A. Archer, F. E. Turkheimer, K. Nagren, R. Bullock, Z. Walker, A. Kennedy, N. C. Fox, et al. Conversion of amyloid positive and negative MCI to AD over 3 years: An 11C-PIB PET study Neurology, September 8, 2009; 73(10): 754 - 760. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. Wang, A. Stucky, J. Liu, C. Shen, C. Trocme-Thibierge, and P. Morain Dissociating {beta}-Amyloid from {alpha}7 Nicotinic Acetylcholine Receptor by a Novel Therapeutic Agent, S 24795, Normalizes {alpha}7 Nicotinic Acetylcholine and NMDA Receptor Function in Alzheimer's Disease Brain J. Neurosci., September 2, 2009; 29(35): 10961 - 10973. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lorena Chaves, A. Luiza Camozzato, C. Godinho, I. Piazenski, and J. Kaye Incidence of Mild Cognitive Impairment and Alzheimer Disease in Southern Brazil J Geriatr Psychiatry Neurol, September 1, 2009; 22(3): 181 - 187. [Abstract] [PDF] |
||||
![]() |
J.-H. Heo, S.-T. Lee, Kon Chu, H.-J. Park, J.-Y. Shim, and M. Kim White Matter Hyperintensities and Cognitive Dysfunction in Alzheimer Disease J Geriatr Psychiatry Neurol, September 1, 2009; 22(3): 207 - 212. [Abstract] [PDF] |
||||
![]() |
N. Purandare Preventing dementia: role of vascular risk factors and cerebral emboli Br. Med. Bull., September 1, 2009; 91(1): 49 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Deschaintre, F. Richard, D. Leys, and F. Pasquier Treatment of vascular risk factors is associated with slower decline in Alzheimer disease Neurology, September 1, 2009; 73(9): 674 - 680. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Jefferies and N. Agrawal Early-onset dementia Adv. Psychiatr. Treat., September 1, 2009; 15(5): 380 - 388. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, N. Schuff, A.-T. Du, H. J. Rosen, J. H. Kramer, M. L. Gorno-Tempini, B. L. Miller, and M. W. Weiner White matter damage in frontotemporal dementia and Alzheimer's disease measured by diffusion MRI Brain, September 1, 2009; 132(9): 2579 - 2592. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Norton, K. W. Piercy, P. V. Rabins, R. C. Green, J. C. S. Breitner, T. Ostbye, C. Corcoran, K. A. Welsh-Bohmer, C. G. Lyketsos, and J. T. Tschanz Caregiver-Recipient Closeness and Symptom Progression in Alzheimer Disease. The Cache County Dementia Progression Study J Gerontol B Psychol Sci Soc Sci, September 1, 2009; 64B(5): 560 - 568. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Tolboom, W. M. van der Flier, M. Yaqub, R. Boellaard, N. A. Verwey, M. A. Blankenstein, A. D. Windhorst, P. Scheltens, A. A. Lammertsma, and B. N.M. van Berckel Relationship of Cerebrospinal Fluid Markers to 11C-PiB and 18F-FDDNP Binding J. Nucl. Med., September 1, 2009; 50(9): 1464 - 1470. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Mitsis, K. M. Reech, F. Bois, G. D. Tamagnan, M. G. MacAvoy, J. P. Seibyl, J. K. Staley, and C. H. van Dyck 123I-5-IA-85380 SPECT Imaging of Nicotinic Receptors in Alzheimer Disease and Mild Cognitive Impairment J. Nucl. Med., September 1, 2009; 50(9): 1455 - 1463. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Thawani, N. Schupf, and E. D. Louis Essential tremor is associated with dementia: Prospective population-based study in New York Neurology, August 25, 2009; 73(8): 621 - 625. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. McDonald, L. K. McEvoy, L. Gharapetian, C. Fennema-Notestine, D. J. Hagler Jr, D. Holland, A. Koyama, J. B. Brewer, A. M. Dale, and For the Alzheimer's Disease Neuroimaging Initiativ Regional rates of neocortical atrophy from normal aging to early Alzheimer disease Neurology, August 11, 2009; 73(6): 457 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Elias, P. K. Elias, S. L. Seliger, S. S. Narsipur, G. A. Dore, and M. A. Robbins Chronic kidney disease, creatinine and cognitive functioning Nephrol. Dial. Transplant., August 1, 2009; 24(8): 2446 - 2452. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Starkstein, R. Mizrahi, A. A. Capizzano, L. Acion, S. Brockman, and B. D. Power Neuroimaging Correlates of Apathy and Depression in Alzheimer's Disease J Neuropsychiatry Clin Neurosci, August 1, 2009; 21(3): 259 - 265. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Banks and S. Weintraub Generalized and Symptom-Specific Insight in Behavioral Variant Frontotemporal Dementia and Primary Progressive Aphasia J Neuropsychiatry Clin Neurosci, August 1, 2009; 21(3): 299 - 306. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Querbes, F. Aubry, J. Pariente, J.-A. Lotterie, J.-F. Demonet, V. Duret, M. Puel, I. Berry, J.-C. Fort, P. Celsis, et al. Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve Brain, August 1, 2009; 132(8): 2036 - 2047. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Desikan, H. J. Cabral, C. P. Hess, W. P. Dillon, C. M. Glastonbury, M. W. Weiner, N. J. Schmansky, D. N. Greve, D. H. Salat, R. L. Buckner, et al. Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease Brain, August 1, 2009; 132(8): 2048 - 2057. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fouquet, B. Desgranges, B. Landeau, E. Duchesnay, F. Mezenge, V. de la Sayette, F. Viader, J.-C. Baron, F. Eustache, and G. Chetelat Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease Brain, August 1, 2009; 132(8): 2058 - 2067. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nelissen, K. Van Laere, L. Thurfjell, R. Owenius, M. Vandenbulcke, M. Koole, G. Bormans, D. J. Brooks, and R. Vandenberghe Phase 1 Study of the Pittsburgh Compound B Derivative 18F-Flutemetamol in Healthy Volunteers and Patients with Probable Alzheimer Disease J. Nucl. Med., August 1, 2009; 50(8): 1251 - 1259. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Stewart, Q.-L. Xue, K. Masaki, H. Petrovitch, G. W. Ross, L. R. White, and L. J. Launer Change in Blood Pressure and Incident Dementia: A 32-Year Prospective Study Hypertension, August 1, 2009; 54(2): 233 - 240. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mattsson, H. Zetterberg, O. Hansson, N. Andreasen, L. Parnetti, M. Jonsson, S.-K. Herukka, W. M. van der Flier, M. A. Blankenstein, M. Ewers, et al. CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment JAMA, July 22, 2009; 302(4): 385 - 393. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Caselli, A. C. Dueck, D. Osborne, M. N. Sabbagh, D. J. Connor, G. L. Ahern, L. C. Baxter, S. Z. Rapcsak, J. Shi, B. K. Woodruff, et al. Longitudinal Modeling of Age-Related Memory Decline and the APOE {epsilon}4 Effect N. Engl. J. Med., July 16, 2009; 361(3): 255 - 263. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hakansson, S. Rovio, E.-L. Helkala, A.-R. Vilska, B. Winblad, H. Soininen, A. Nissinen, A. H Mohammed, and M. Kivipelto Association between mid-life marital status and cognitive function in later life: population based cohort study BMJ, July 2, 2009; 339(jul02_2): b2462 - b2462. [Abstract] [Full Text] [PDF] |
||||
![]() |
G J Kinsella, E Mullaly, E Rand, B Ong, C Burton, S Price, M Phillips, and E Storey Early intervention for mild cognitive impairment: a randomised controlled trial J. Neurol. Neurosurg. Psychiatry, July 1, 2009; 80(7): 730 - 736. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kroger, R. Verreault, P.-H. Carmichael, J. Lindsay, P. Julien, E. Dewailly, P. Ayotte, and D. Laurin Omega-3 fatty acids and risk of dementia: the Canadian Study of Health and Aging Am. J. Clinical Nutrition, July 1, 2009; 90(1): 184 - 192. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E Devore, F. Grodstein, F. J. van Rooij, A. Hofman, B. Rosner, M. J Stampfer, J. C. Witteman, and M. M. Breteler Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk Am. J. Clinical Nutrition, July 1, 2009; 90(1): 170 - 176. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Richardson, S. L. Shalat, B. Buckley, B. Winnik, P. O'Suilleabhain, R. Diaz-Arrastia, J. Reisch, and D. C. German Elevated Serum Pesticide Levels and Risk of Parkinson Disease Arch Neurol, July 1, 2009; 66(7): 870 - 875. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Chow, M. A. Binns, J. L. Cummings, I. Lam, S. E. Black, B. L. Miller, M. Freedman, D. T. Stuss, and R. van Reekum Apathy Symptom Profile and Behavioral Associations in Frontotemporal Dementia vs Dementia of Alzheimer Type Arch Neurol, July 1, 2009; 66(7): 888 - 893. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Larner 'Attended alone' sign: validity and reliability for the exclusion of dementia Age Ageing, July 1, 2009; 38(4): 476 - 478. [Full Text] [PDF] |
||||
![]() |
E. L. Sampson, M. R. Blanchard, L. Jones, A. Tookman, and M. King Dementia in the acute hospital: prospective cohort study of prevalence and mortality The British Journal of Psychiatry, July 1, 2009; 195(1): 61 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Peters, F. Collette, C. Degueldre, V. Sterpenich, S. Majerus, and E. Salmon The neural correlates of verbal short-term memory in Alzheimer's disease: an fMRI study Brain, July 1, 2009; 132(7): 1833 - 1846. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. N. Arsenault, N. Matthan, T. M. Scott, G. Dallal, A. H. Lichtenstein, M. F. Folstein, I. Rosenberg, and K. L. Tucker Validity of Estimated Dietary Eicosapentaenoic Acid and Docosahexaenoic Acid Intakes Determined by Interviewer-Administered Food Frequency Questionnaire Among Older Adults With Mild-to-Moderate Cognitive Impairment or Dementia Am. J. Epidemiol., July 1, 2009; 170(1): 95 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Buchman, P. A. Boyle, R. S. Wilson, D. A. Fleischman, S. Leurgans, and D. A. Bennett Association Between Late-Life Social Activity and Motor Decline in Older Adults Arch Intern Med, June 22, 2009; 169(12): 1139 - 1146. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Lu, S. D. Edland, E. Teng, K. Tingus, R. C. Petersen, J. L. Cummings, and On behalf of The Alzheimer's Disease Cooperative S Donepezil delays progression to AD in MCI subjects with depressive symptoms Neurology, June 16, 2009; 72(24): 2115 - 2121. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Brown, G. Pengas, K. Dawson, L. A Brown, and P. Clatworthy Self administered cognitive screening test (TYM) for detection of Alzheimer's disease: cross sectional study BMJ, June 9, 2009; 338(jun08_3): b2030 - b2030. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.C.S. Breitner, S. J.P.A. Haneuse, R. Walker, S. Dublin, P. K. Crane, S. L. Gray, and E. B. Larson Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort Neurology, June 2, 2009; 72(22): 1899 - 1905. [Abstract] [Full Text] [PDF] |
||||
![]() |
S S Williams, J Williams, M Combrinck, S Christie, A D Smith, and R McShane Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease J. Neurol. Neurosurg. Psychiatry, June 1, 2009; 80(6): 667 - 670. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gyurak, M. S. Goodkind, A. Madan, J. H. Kramer, B. L. Miller, and R. W. Levenson Do tests of executive functioning predict ability to downregulate emotions spontaneously and when instructed to suppress? Cogn Affect Behav Neurosci, June 1, 2009; 9(2): 144 - 152. [Abstract] [PDF] |
||||
![]() |
O L Lopez, J T Becker, A S Wahed, J Saxton, R A Sweet, D A Wolk, W Klunk, and S T DeKosky Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease J. Neurol. Neurosurg. Psychiatry, June 1, 2009; 80(6): 600 - 607. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Wilson, N. T. Aggarwal, L. L. Barnes, J. L. Bienias, C. F. Mendes de Leon, and D. A. Evans Biracial Population Study of Mortality in Mild Cognitive Impairment and Alzheimer Disease Arch Neurol, June 1, 2009; 66(6): 767 - 772. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Leyhe, M. Milian, S. Muller, G. W. Eschweiler, and R. Saur The Minute Hand Phenomenon in the Clock Test of Patients With Early Alzheimer Disease J Geriatr Psychiatry Neurol, June 1, 2009; 22(2): 119 - 129. [Abstract] [PDF] |
||||
![]() |
C. H. Sadowsky, A. Dengiz, J. T. Olin, B. Koumaras, X. Meng, S. Brannan, and US38 study group Switching from Donepezil Tablets to Rivastigmine Transdermal Patch in Alzheimer's Disease American Journal of Alzheimer's Disease and Other Dementias, June 1, 2009; 24(3): 267 - 275. [Abstract] [PDF] |
||||
![]() |
B. Bediou, I. Ryff, B. Mercier, M. Milliery, M.-A. Henaff, T. D'Amato, M. Bonnefoy, A. Vighetto, and P. Krolak-Salmon Impaired Social Cognition in Mild Alzheimer Disease J Geriatr Psychiatry Neurol, June 1, 2009; 22(2): 130 - 140. [Abstract] [PDF] |
||||
![]() |
J. Verghese, Cuiling Wang, M. J. Katz, A. Sanders, and R. B. Lipton Leisure Activities and Risk of Vascular Cognitive Impairment in Older Adults J Geriatr Psychiatry Neurol, June 1, 2009; 22(2): 110 - 118. [Abstract] [PDF] |
||||
![]() |
M. F. Mendez, A. M. McMurtray, E. A. Licht, and R. E. Saul Frontal-executive Versus Posterior-perceptual Mental Status Deficits in Early-onset Dementias American Journal of Alzheimer's Disease and Other Dementias, June 1, 2009; 24(3): 220 - 227. [Abstract] [PDF] |
||||
![]() |
V. J. Lowe, B. J. Kemp, C. R. Jack Jr., M. Senjem, S. Weigand, M. Shiung, G. Smith, D. Knopman, B. Boeve, B. Mullan, et al. Comparison of 18F-FDG and PiB PET in Cognitive Impairment J. Nucl. Med., June 1, 2009; 50(6): 878 - 886. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. C. Maes, H. M. Schipper, H. M. Chertkow, and E. Wang Methodology for Discovery of Alzheimer's Disease Blood-Based Biomarkers J Gerontol A Biol Sci Med Sci, June 1, 2009; 64A(6): 636 - 645. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Boyle, L. L. Barnes, A. S. Buchman, and D. A. Bennett Purpose in Life Is Associated With Mortality Among Community-Dwelling Older Persons Psychosom Med, June 1, 2009; 71(5): 574 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
S-T Lee, K. Chu, K-H Jung, H-K Park, D-H Kim, J-J Bahn, J-H Kim, M-J Oh, S. K. Lee, M. Kim, et al. Reduced circulating angiogenic cells in Alzheimer disease Neurology, May 26, 2009; 72(21): 1858 - 1863. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bosch-Domenech, R. Nagel, and J. V. Sanchez-Andres Prosocial Capabilities in Alzheimer's Patients J Gerontol B Psychol Sci Soc Sci, May 25, 2009; (2009) gbp034v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Jessen, O. Gur, W. Block, G. Ende, L. Frolich, T. Hammen, J. Wiltfang, T. Kucinski, H. Jahn, R. Heun, et al. A multicenter 1H-MRS study of the medial temporal lobe in AD and MCI Neurology, May 19, 2009; 72(20): 1735 - 1740. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. F. Hughes, A. R. Borenstein, E. Schofield, Y. Wu, and E. B. Larson Association between late-life body mass index and dementia: The Kame Project Neurology, May 19, 2009; 72(20): 1741 - 1746. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.D.M. Haag, A. Hofman, P. J. Koudstaal, M. M.B. Breteler, and B. H.C. Stricker Duration of antihypertensive drug use and risk of dementia: A prospective cohort study Neurology, May 19, 2009; 72(20): 1727 - 1734. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Smith Treatment of Alzheimer's disease in the long-term-care setting Am. J. Health Syst. Pharm., May 15, 2009; 66(10): 899 - 907. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |